<DOC>
	<DOC>NCT00734292</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the early bronchodilating effect of SKP FlutiForm HFA pMDI compared to placebo.</brief_summary>
	<brief_title>Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects with documented history of mild to moderate asthma currently taking a stable dose of inhaled corticosteroid Participation in a prior FlutiForm study Smoking history within the last 12 months, Significant, nonreversible, pulmonary disease Lifethreatening asthma within the last year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Asthma Mild to Moderate</keyword>
</DOC>